Your browser is no longer supported. Please, upgrade your browser.
Settings
ABBV AbbVie Inc. daily Stock Chart
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E17.46 EPS (ttm)5.08 Insider Own0.07% Shs Outstand1.51B Perf Week4.60%
Market Cap133.97B Forward P/E10.20 EPS next Y8.70 Insider Trans-20.96% Shs Float1.49B Perf Month6.15%
Income7.93B PEG1.00 EPS next Q1.93 Inst Own72.20% Short Float1.99% Perf Quarter-1.38%
Sales32.19B P/S4.16 EPS this Y-2.40% Inst Trans0.04% Short Ratio4.10 Perf Half Y-0.28%
Book/sh-1.93 P/B- EPS next Y9.31% ROA11.20% Target Price97.18 Perf Year-15.27%
Cash/sh5.81 P/C15.25 EPS next 5Y17.42% ROE- 52W Range77.50 - 125.86 Perf YTD-3.83%
Dividend4.28 P/FCF19.81 EPS past 5Y1.20% ROI17.80% 52W High-29.56% Beta1.34
Dividend %4.83% Quick Ratio1.10 Sales past 5Y9.00% Gross Margin76.30% 52W Low14.40% ATR2.55
Employees30000 Current Ratio1.20 Sales Q/Q17.70% Oper. Margin33.00% RSI (14)51.85 Volatility2.03% 2.99%
OptionableYes Debt/Eq- EPS Q/Q78.30% Profit Margin23.40% Rel Volume0.78 Prev Close89.50
ShortableYes LT Debt/Eq- EarningsJan 25 BMO Payout67.50% Avg Volume7.26M Price88.66
Recom2.70 SMA200.79% SMA500.71% SMA200-4.83% Volume5,658,614 Change-0.94%
Jan-03-19Downgrade BofA/Merrill Buy → Neutral
Dec-26-18Initiated Standpoint Research Buy
Oct-22-18Reiterated SunTrust Buy $157 → $135
Oct-04-18Reiterated BofA/Merrill Buy $107 → $106
Jun-01-18Downgrade Piper Jaffray Overweight → Neutral
May-30-18Downgrade Credit Suisse Neutral → Underperform
Jan-30-18Reiterated Morgan Stanley Equal-Weight $99 → $131
Jan-29-18Downgrade Leerink Partners Outperform → Mkt Perform
Oct-30-17Reiterated Leerink Partners Outperform $108 → $107
Oct-02-17Upgrade Leerink Partners Mkt Perform → Outperform
Sep-25-17Downgrade UBS Buy → Neutral $79 → $92
Aug-17-17Initiated Evercore ISI Outperform $95
Jun-22-17Upgrade Societe Generale Hold → Buy
Mar-22-17Upgrade Societe Generale Sell → Hold
Oct-31-16Downgrade Credit Suisse Outperform → Neutral
Oct-18-16Initiated Leerink Partners Mkt Perform $70
Sep-08-16Downgrade JP Morgan Overweight → Neutral
Sep-02-16Initiated Raymond James Outperform $82
Jun-08-16Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-06-16Initiated Societe Generale Sell $47
Jan-22-19 11:22AM  5 Amazing Earnings Charts Zacks
09:57AM  J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft Zacks
08:31AM  Bet on These 5 Low Leverage Stocks to Secure Returns Zacks
06:06AM  Better Buy: Pfizer vs. AbbVie Motley Fool
Jan-21-19 02:08PM  AbbVie's Imbruvica Fails in Phase III Pancreatic Cancer Study Zacks
08:23AM  Zacks Value Trader Highlights: Crocs, Five Below, AbbVie and J.Jill Zacks
07:50AM  What's in Store for Bristol-Myers (BMY) in Q4 Earnings? Zacks
Jan-20-19 03:00PM  Earnings, Davos - What to know in the week ahead Yahoo Finance
11:30AM  Better Buy: AbbVie vs. Johnson & Johnson Motley Fool
05:54AM  Top Marijuana Stocks That Pay Dividends Investopedia
Jan-18-19 09:06PM  Lockheed Martin and Other Big Names From a Small-Caps Specialist Barrons.com
05:45PM  AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study Reuters
04:42PM  AbbVie's cancer drug fails to meet main goal in late-stage study Reuters
04:29PM  AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Metastatic Pancreatic Cancer PR Newswire
10:30AM  AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth Zacks
10:10AM  Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive? Zacks
Jan-17-19 11:49PM  Are you a Tortoise or a Hare Investor? Zacks
07:06PM  Pacira's Study on Exparel Label Expansion Meets Endpoints Zacks
09:15AM  Banks Keep Stocks Moving Higher Zacks
08:48AM  Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon Zacks
07:00AM  Trending: Investors Turn to Dividend Aristocrats Amid Market Volatility ETF Database
Jan-16-19 04:26PM  Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings Zacks
03:04PM  3 Healthcare Stocks That Will Keep Your Portfolio Healthy InvestorPlace
12:28PM  Will Dividend Stocks be the Hot Stocks of 2019? Zacks
06:26AM  Katz: Markets are looking past several negative headline... CNBC Videos
Jan-15-19 03:04PM  3 of the Top Big Pharma Stocks to Buy Now InvestorPlace
02:09PM  Drug companies greet 2019 with U.S. price hikes Reuters
Jan-14-19 06:00PM  Democrats target drug prices CNBC Videos
05:52PM  Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe Investor's Business Daily
04:08PM  U.S. lawmaker launches investigation into pharma drug pricing Reuters
12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
07:57AM  Top Ranked Growth Stocks to Buy for January 14th Zacks
Jan-13-19 09:00AM  3 Top Dividend Stocks Selling at a Discount Right Now Motley Fool
Jan-11-19 05:36PM  5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019 Zacks
03:45PM  3 Back-of-the-Shelf Consumer Stocks With Growth and Income InvestorPlace
10:19AM  Top Ranked Momentum Stocks to Buy for January 11th Zacks
09:45AM  Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet Zacks
Jan-10-19 11:56PM  [$$] Senator Collins Presses HHS to Reform Drug Rebate System The Wall Street Journal
02:48PM  101 Best Dividend Stocks to Buy for 2019 and Beyond Kiplinger
11:51AM  6 High-Cap Stocks Paying High Dividend Yields GuruFocus.com
08:18AM  3 Dividend Stocks That Pay You Better Than Coca-Cola Does Motley Fool
08:15AM  3 Big Reasons Why AbbVie Isn't Worried About Humira Motley Fool
06:31AM  Top Ranked Momentum Stocks to Buy for January 10th Zacks
Jan-09-19 10:38AM  AbbVie Falls 3% Investing.com
09:10AM  Is AbbVie (ABBV) a Great Value Stock Right Now? Zacks
08:48AM  The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy Zacks
08:31AM  Novartis' Crizanlizumab Gets Breakthrough Therapy Status Zacks
07:38AM  Inside look: LNG bunker that puts Jaxport on world map American City Business Journals
05:00AM  Top Picks 2019- AbbVie Inc. ABBV MoneyShow
Jan-08-19 02:27PM  Top Analyst Reports for Visa, Coca-Cola & AbbVie Zacks
Jan-07-19 05:45PM  AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know Zacks
05:18PM  Peninsula Alzheimer's fighter hunts $150 million IPO American City Business Journals
12:42PM  Neurocrine Gives Ingrezza Sales View, Updates on Pipeline Zacks
10:56AM  As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock InvestorPlace
09:09AM  Gilead (GILD) Collaborates With Yuhan for NASH Candidates Zacks
07:47AM  Jim Cramer Gives His Opinion On Ciena, Momo, Qualcomm And More Benzinga
07:15AM  Neurocrine Biosciences Is a Pharma Stock to Watch InvestorPlace
07:00AM  Today's Research Reports on Trending Tickers: AbbVie and Allergan ACCESSWIRE
04:00AM  The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie Zacks
Jan-06-19 06:01PM  3 Bargain Stocks You Can Buy Right Now Motley Fool
04:20PM  Abbvie: Time to Buy This Dividend Stock? GuruFocus.com
Jan-04-19 08:22PM  [$$] AbbVie to Record $4 Billion Impairment on Stemcentrx Assets The Wall Street Journal
07:04PM  Cramer's lightning round: 'Do some trimming' in Qualcomm ... CNBC Videos
06:50PM  Cramer's lightning round: 'Do some trimming' in Qualcomm if the stock rallies CNBC
06:09PM  AbbVie (ABBV) Inks Immunotherapy Deal with Private Biotech Zacks
05:11PM  Which Biopharma Stocks Are Looking To Score Big In Cannabis Medicine? Investor's Business Daily
10:07AM  Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate Zacks
08:08AM  AbbVie Rises 3% Investing.com
07:29AM  Pfizer Begins Pivotal Study on Alopecia Areata Candidate Zacks
Jan-03-19 04:13PM  Bristol-Myers Angles To Become Mega-Pharma With $74 Billion Celgene Bid Investor's Business Daily
12:35PM  3 Biopharma Stocks to Buy for Their Robust Dividend Yields InvestorPlace
10:24AM  Bristol-Myers Angles To Become Mega-Pharma With $74 Billion Celgene Bid Investor's Business Daily
10:12AM  Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019? Zacks
08:30AM  AbbVie and Tizona Therapeutics Announce Strategic Collaboration to Develop First-in-Class Immunotherapy for Cancer Targeting CD39 PR Newswire
08:16AM  AbbVie Falls 3% Investing.com
08:04AM  3 Big Stock Charts for Thursday: Medtronic, Facebook and eBay InvestorPlace
08:00AM  AbbVie to Host Fourth-Quarter and Full-Year 2018 Earnings Conference Call PR Newswire
Jan-02-19 01:53PM  Drug companies greet 2019 with U.S. price hikes Reuters
01:29PM  Drug companies greet 2019 with U.S. price hikes Reuters
01:03PM  Stay with IBM? What's up with Blackstone? That and more i... CNBC Videos
04:52AM  AbbVie Falls 3% Investing.com
Dec-31-18 05:45PM  AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know Zacks
08:49AM  The Most Promising Biotech Names Heading Into 2019 Investopedia
Dec-28-18 02:49PM  AbbVie: A Low-Risk Income Stock That Gives Investors Exposure to the Marijuana Industry GuruFocus.com
10:11AM  2019 biotech preview: Money is pouring into the Bay Area and so is Big Pharma American City Business Journals
09:58AM  AbbVie Rises 3% Investing.com
09:46AM  Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019? Zacks
Dec-27-18 01:50PM  The Humira Overhang Cant Cast a Shadow on AbbVie Stock Forever InvestorPlace
09:35AM  AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV InvestorPlace
Dec-26-18 01:25PM  Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players? Investor's Business Daily +5.80%
10:04AM  AbbVie Partners Lupin to Boost Hematological Cancer Pipeline Zacks
05:18AM  AbbVie Rises 3% Investing.com
Dec-24-18 05:45PM  AbbVie (ABBV) Stock Moves -0.89%: What You Should Know Zacks
Dec-22-18 12:00PM  Better Buy: AbbVie vs. Merck Motley Fool
Dec-21-18 02:52PM  AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib Zacks
Dec-20-18 05:59PM  Gilead Partners with Scholar Rock for Fibrotic Disease Drugs Zacks
05:18PM  AbbVie Rises 3% Investing.com
08:50AM  AbbVie Submits New Drug Application to U.S. FDA and Marketing Authorization Application to EMA for Upadacitinib for Treatment of Adults with Moderate to Severe Rheumatoid Arthritis PR Newswire
08:00AM  AbbVie to Present at the 37th Annual J.P. Morgan Healthcare Conference PR Newswire
06:00AM  3 Top Healthcare Stocks to Buy in December Motley Fool
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune diseases; IMBRUVICA, an oral therapy for treating chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C. It also provides Kaletra, an anti- human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid for hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, endometriosis, and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product for human use; and ZINBRYTA, a treatment for relapsing forms of multiple sclerosis. It serves wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers. AbbVie Inc. has collaborations with Alector, Inc.; C2N Diagnostics; Voyager Therapeutics, Inc.; Janssen Biotech, Inc.; International Myeloma Foundation; Calibr and Scripps Research; The Institute for Research in Immunology and Cancer Commercialization of Research; the Universite de Montreal; Tolero Pharmaceuticals, Inc.; Galapagos; Mission Therapeutics Ltd; Bristol-Myers Squibb Company; Voluntis; and Tizona Therapeutics, Inc. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schumacher Laura JVice ChairmanDec 28Sale90.0025,0002,250,000134,322Jan 02 04:49 PM
CHASE WILLIAM JEVP, Finance & AdministrationDec 12Sale90.0060,0005,400,000104,863Dec 14 05:12 PM
GONZALEZ RICHARD AChairman of the Board and CEODec 11Sale88.7516,8501,495,438286,203Dec 13 04:56 PM
Schumacher Laura JExecutive Vice PresidentDec 04Option Exercise51.4294,1404,840,679192,398Dec 07 05:15 PM
Schumacher Laura JExecutive Vice PresidentDec 04Sale93.5894,1408,809,55298,258Dec 07 05:15 PM
Gosebruch Henry OEVP, Chief Strategy OfficerNov 29Sale90.1042,4503,824,94030,350Nov 30 05:22 PM
SEVERINO MICHAELEVP, R&D and CSOAug 17Sale97.5250,0004,876,06082,281Aug 21 04:58 PM
TILTON GLENN FDirectorJun 27Buy91.905,400496,27439,735Jun 29 02:30 PM
RAPP EDWARD JDirectorJun 20Buy98.631,01399,90920,743Jun 22 05:56 PM
ALBAN CARLOSEVP, Commercial OperationsMar 01Option Exercise29.2348,1001,405,795178,547Mar 02 05:29 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 01Option Exercise25.9132,400839,339197,263Mar 02 05:28 PM
ALBAN CARLOSEVP, Commercial OperationsMar 01Sale114.3980,9959,264,80897,552Mar 02 05:29 PM
Schumacher Laura JExecutive Vice PresidentMar 01Sale117.8525,0002,946,14898,317Mar 02 05:28 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 01Sale114.5032,4003,709,687164,863Mar 02 05:28 PM
Michael Robert A.VP, ControllerFeb 28Sale119.434,294512,8536,876Mar 02 05:31 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 28Sale117.771,337157,45893,312Mar 02 05:31 PM
SEVERINO MICHAELEVP, R&D and CSOFeb 28Sale117.932,643311,684132,281Mar 02 05:30 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 28Sale118.6718,1292,151,45217,588Mar 02 05:30 PM
CHASE WILLIAM JEVP, Chief Financial OfficerFeb 28Sale119.4438,5284,601,954164,863Mar 02 05:28 PM
ALBAN CARLOSEVP, Commercial OperationsFeb 28Sale117.852,579303,928130,447Mar 02 05:29 PM
GONZALEZ RICHARD AChairman of the Board and CEOFeb 28Sale117.888,280976,084313,012Mar 02 05:28 PM
Michael Robert A.VP, ControllerFeb 20Sale120.31992119,35113,557Feb 20 06:08 PM